For many years, the medical use of cannabis—also known as marijuana—to treat cancer-related symptoms like pain, nausea, and loss of appetite has been debated. One major reason for the lack of clarity was the legal restrictions on cannabis research.
In many countries, including the U.S., cannabis has been classified as a Schedule I controlled substance, putting it in the same category as heroin and LSD. This made it very difficult for scientists to carry out proper research and slowed progress toward understanding its real medical value.
Now, a groundbreaking new study may help change that. Researchers from the Whole Health Oncology Institute and the Chopra Foundation reviewed more than 10,000 peer-reviewed scientific papers about cannabis and health outcomes.
The results, published in the journal Frontiers in Oncology, offer strong support for using medical cannabis in cancer care—not just to manage symptoms, but potentially as a treatment for the disease itself.
Cannabis contains chemical compounds called cannabinoids. The two best-known ones are THC (tetrahydrocannabinol), which is responsible for the “high,” and CBD (cannabidiol), which does not cause a high.
Both THC and CBD interact with a network in the human body called the endocannabinoid system. This system plays a role in controlling pain, mood, sleep, and other key body functions. When cannabinoids interact with this system, they can produce therapeutic effects.
The researchers used advanced artificial intelligence tools to sift through data from the more than 10,000 studies. In total, they examined nearly 40,000 specific data points on cannabis and health.
A technique called natural language processing—a type of AI that helps computers understand human language—was used to analyze the overall tone of the research. This “sentiment analysis” helped the researchers identify whether studies supported or did not support the medical use of cannabis, or if they were unclear.
The results were striking. The number of studies that supported the use of medical cannabis for cancer was over 31 times greater than those that did not support it, and 36 times greater than those that were neutral or uncertain.
This overwhelming majority in favor of medical cannabis provides powerful evidence that it can be useful in improving quality of life for cancer patients and may even have antitumor effects.
Cannabis has been shown to help with many common problems faced by cancer patients. These include the pain caused by tumors or treatment, the nausea that often comes with chemotherapy, and the loss of appetite that can lead to unhealthy weight loss.
Beyond these well-known benefits, some studies also suggest cannabis may directly affect the growth and spread of cancer cells—although more research is needed to confirm this.
Despite growing evidence, cannabis remains underused in mainstream cancer treatment. The researchers behind this large-scale review hope their findings will encourage a shift in how the medical community and public view cannabis.
They argue that cannabis should be reconsidered not just as an alternative remedy, but as a potential part of standard cancer care. They also hope the results will support future policy changes, funding decisions, and clinical guidelines that make it easier for patients to access cannabis where it’s legal.
In conclusion, this study provides some of the strongest support yet for medical cannabis in cancer care. It shows that, across thousands of studies, the science overwhelmingly backs its value in managing cancer symptoms and possibly even treating the disease itself.
With more research and open-minded clinical discussions, medical cannabis may become a more widely accepted part of cancer treatment in the years ahead.
If you care about cancer, please read studies about a new method to treat cancer effectively, and this low-dose, four-drug combo may block cancer spread.
For more information about cancer prevention, please see recent studies about nutrient in fish that can be a poison for cancer, and results showing this daily vitamin is critical to cancer prevention.
The research findings can be found in Frontiers in Oncology.
Copyright © 2025 Knowridge Science Report. All rights reserved.
